The Unique Role of the Community Pharmacist in the Management of Moderate-to-Severe Atopic Dermatitis in the Pediatric Population

 

REGISTER FOR LIVE PROGRAM

REGISTER FOR LIVE SIMULCAST

 

A Midday Symposium conducted at the 2018 ASHP Midyear Clinical Meeting and Exhibition

 

Wednesday, December 5, 2018

10:45 – 11:30 AM: Registration
11:30 – 1:00 PM: Symposium

Anaheim Convention Center
800 W Katella Avenue
Anaheim CA 92802
Meeting room: Room 258, 200 Level, ACC North

PROGRAM FEATURES

    • 1.50 CME credits
    • Virtual reality headsets provided to enhance learning experience (for viewing this presentation only)
    • Interactive, case-based learning environment

FACULTY

Lindsay Strowd, MD, FAAD
Assistant Professor of Dermatology
Wake Forest Baptist Health
Winston-Salem, NC

Geoffrey C. Wall, PharmD, FCCP, BCPS
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Consulting Partner
Medical Intelligence Group, PLLC
Des Moines, IA

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Describe recent pathophysiological findings in AD that have informed the selection of new therapeutic targets
  • Identify best practices for severity assessment and diagnosis of moderate-to-severe AD in pediatric patients, accounting for biomarkers, phenotype/genotype, comorbidities, and disease burden
  • Review the clinical profiles and mechanisms of action of the new and emerging targeted agents for the treatment of pediatric patients with AD
  • Explain how different comorbidities and adherence barriers play a role in the choice of treatment regimens for pediatric patients with AD
  • Discuss the benefits of patient-centered health care management teams for pediatric patients with AD and the respective roles of team members

TARGET AUDIENCE

This activity is intended for US-based pharmacists involved in the management of pediatric patients with AD.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with pediatric atopic dermatitis.

Credits: 1.5 ANCC Contact Hours

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.5 contact hours of continuing nursing education of RNs and APNs.

PHARMACY CREDIT INFORMATION

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MedLearning Group.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.5 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

UAN: Pharmacists: JA4008163-9999-18-051-L04-P; Pharmacy Technician: JA4008163-9999-18-051-L04-T

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

 

REGISTER FOR LIVE PROGRAM

REGISTER FOR LIVE SIMULCAST

 

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.